Kaskela Law LLC announces that it is investigating 23andMe Holding Co. (“23andMe”) (NASDAQ: ME) on behalf of the Company’s investors.
Since November 2021, shares of 23andMe’s common stock have declined in value from a trading price of over $12.50 per share to a current trading price of less than $3.50 per share, a cumulative decline of over $9.00 per share, or 72% in value.
The investigation seeks to determine whether 23andMe and/or the company’s representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to 23andMe investors, thereby causing investor losses.
23andMe stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.